CC BY-NC-ND 4.0 · Sleep Sci 2024; 17(01): e37-e44
DOI: 10.1055/s-0043-1776741
Original Article

Sleep Restfulness in Patients with Obstructive Sleep Apnea Undergoing Continuous Positive Airway Pressure Therapy

1   Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Jumpei Togawa
2   Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Hironobu Sunadome
2   Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Tadao Nagasaki
2   Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Naomi Takahashi
2   Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Toyohiro Hirai
3   Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Susumu Sato
2   Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
› Author Affiliations
Funding The Department of Advanced Medicine for Respiratory Failure is a Department of Collaborative Research Laboratory funded by Teijin Pharma. The Department of Respiratory Care and Sleep Control Medicine is funded by endowments from Philips Japan, ResMed Japan, Fukuda Denshi and Fukuda Lifetec-Keiji to Kyoto University. This study was funded in part by the JSPS KAKENHI 22K16169 (SH).

Abstract

Objective Sleep restfulness is closely associated with mortality. Thus, it is an important sleep-related symptom in the general population. However, it is rarely evaluated in patients with obstructive sleep apnea (OSA) syndrome. The present study examined the importance of sleep restfulness in patients with OSA receiving continuous positive airway pressure (CPAP) therapy.

Materials and Methods We administered sleep-related questionnaires, which included items such as subjective sleep duration and sleep restfulness, to 775 patients with OSA receiving CPAP therapy. Sleep restfulness was rated using a 5-point Likert-type scale, with the score of 5 indicating restfulness. Good adherence to CPAP therapy was defined as the use of CPAP therapy for at least 4 h per night in 70% of nights.

Results We excluded 105 patients with lacking data. Thus, 670 patients were finally examined. In total, 29 (4.3%), 124 (18.5%), 139 (20.8%), 235 (35.1%), and 143 (14.3%) patients answered restless (1), somewhat restless (2), neither (3), somewhat restful (4), and restful (5) respectively. A total of 467 (69.7%) patients had good adherence to CPAP therapy. Multivariate logistic regression analysis showed that sleep restfulness was independently and positively associated with subjective sleep duration (≥ 7 hours) and good adherence to CPAP therapy.

Conclusion Sleep restfulness was associated with subjective sleep duration and good adherence to CPAP therapy in patients with OSA. Favorable outcomes are significantly correlated with good adherence to CPAP therapy. Thus, sleep restfulness can be an indicator of a subtype that has favorable outcomes in patients after CPAP therapy.



Publication History

Received: 11 December 2022

Accepted: 08 May 2023

Article published online:
15 February 2024

© 2024. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Benjafield AV, Ayas NT, Eastwood PR. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7 (08) 687-698
  • 2 Randerath W, Bassetti CL, Bonsignore MR. et al. Challenges and perspectives in obstructive sleep apnoea: Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society. Eur Respir J 2018; 52 (03) 1702616
  • 3 Lévy P, Kohler M, McNicholas WT. et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 2015; 1: 15015
  • 4 Lal C, Weaver TE, Bae CJ, Strohl KP. Mechanisms and Clinical Management. Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management. Ann Am Thorac Soc 2021; 18 (05) 757-768
  • 5 Jonas DE, Amick HR, Feltner C. et al. Screening for obstructive sleep apnea in adults: Evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017; 317 (04) 415-433
  • 6 Sánchez-de-la-Torre M, Gracia-Lavedan E, Benítez ID. et al; Spanish Sleep Network. Long-term Effect of obstructive sleep apnea and continuous positive airway pressure treatment on blood pressure in patients with acute coronary syndrome: A clinical trial. Ann Am Thorac Soc 2022; 19 (10) 1750-1759
  • 7 Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: A systematic review and meta-analysis. JAMA 2015; 314 (21) 2280-2293
  • 8 Lin HJ, Yeh JH, Hsieh MT, Hsu CY. Continuous positive airway pressure with good adherence can reduce risk of stroke in patients with moderate to severe obstructive sleep apnea: An updated systematic review and meta-analysis. Sleep Med Rev 2020; 54: 101354
  • 9 Khan SU, Duran CA, Rahman H, Lekkala M, Saleem MA, Kaluski E. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur Heart J 2018; 39 (24) 2291-2297
  • 10 Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S. et al; Spanish Sleep Network. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med 2020; 8 (04) 359-367
  • 11 Gooneratne NS, Richards KC, Joffe M. et al. Sleep disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults. Sleep 2011; 34 (04) 435-442
  • 12 Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994; 17 (08) 703-710
  • 13 Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med 2021; 133 (07) 772-783
  • 14 Kingshott RN, Sime PJ, Engleman HM, Douglas NJ. Self assessment of daytime sleepiness: patient versus partner. Thorax 1995; 50 (09) 994-995
  • 15 Sauter C, Asenbaum S, Popovic R. et al. Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome. J Sleep Res 2000; 9 (03) 293-301
  • 16 Kendzerska TB, Smith PM, Brignardello-Petersen R, Leung RS, Tomlinson GA. Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review. Sleep Med Rev 2014; 18 (04) 321-331
  • 17 Gagnadoux F, Le Vaillant M, Paris A. et al; Institut de Recherche en Santé Respiratoire des Pays de la Loire Sleep Cohort Group. Relationship between OSA clinical phenotypes and CPAP treatment outcomes. Chest 2016; 149 (01) 288-290
  • 18 Ye L, Pien GW, Ratcliffe SJ. et al. The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 2014; 44 (06) 1600-1607
  • 19 Pack AI, Magalang UJ, Singh B, Kuna ST, Keenan BT, Maislin G. Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias. Sleep 2021; 44 (02) zsaa229
  • 20 Mazzotti DR, Keenan BT, Lim DC, Gottlieb DJ, Kim J, Pack AI. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med 2019; 200 (04) 493-506
  • 21 Labarca G, Dreyse J, Salas C, Letelier F, Jorquera J. A validation study of four different cluster analyses of OSA and the incidence of cardiovascular mortality in a Hispanic population. Chest 2021; 160 (06) 2266-2274
  • 22 Allen AJH, Jen R, Mazzotti DR. et al. Symptom subtypes and risk of incident cardiovascular and cerebrovascular disease in a clinic-based obstructive sleep apnea cohort. J Clin Sleep Med 2022; 18 (09) 2093-2102
  • 23 Pien GW, Ye L, Keenan BT. et al. Changing faces of obstructive sleep apnea: Treatment effects by cluster designation in the Icelandic Sleep Apnea Cohort. Sleep 2018; 41 (03) zsx201
  • 24 Mazzotti DR, Keenan BT, Thorarinsdottir EH, Gislason T, Pack AI. Sleep Apnea Global Interdisciplinary Consortium. Is the Epworth Sleepiness Scale sufficient to identify the excessively sleepy subtype of OSA?. Chest 2022; 161 (02) 557-561
  • 25 Kaneko H, Itoh H, Kiriyama H. et al. Restfulness from sleep and subsequent cardiovascular disease in the general population. Sci Rep 2020; 10 (01) 19674
  • 26 Yoshiike T, Utsumi T, Matsui K. et al. Mortality associated with nonrestorative short sleep or nonrestorative long time-in-bed in middle-aged and older adults. Sci Rep 2022; 12 (01) 189
  • 27 Schwab RJ, Badr SM, Epstein LJ. et al; ATS Subcommittee on CPAP Adherence Tracking Systems. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 2013; 188 (05) 613-620
  • 28 Takegami M, Suzukamo Y, Wakita T. et al. Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. Sleep Med 2009; 10 (05) 556-565
  • 29 Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010; 33 (05) 585-592
  • 30 Itani O, Kaneita Y, Tokiya M. et al. Short sleep duration, shift work, and actual days taken off work are predictive life-style risk factors for new-onset metabolic syndrome: a seven-year cohort study of 40,000 male workers. Sleep Med 2017; 39: 87-94
  • 31 Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011; 32 (12) 1484-1492
  • 32 Leng Y, Cappuccio FP, Wainwright NW. et al. Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis. Neurology 2015; 84 (11) 1072-1079
  • 33 Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 2014; 21 (01) 57-64
  • 34 Clark AJ, Salo P, Lange T. et al. Onset of impaired sleep and cardiovascular disease risk factors: A longitudinal study. Sleep 2016; 39 (09) 1709-1718
  • 35 Ensrud KE, Blackwell TL, Ancoli-Israel S. et al. Sleep disturbances and risk of frailty and mortality in older men. Sleep Med 2012; 13 (10) 1217-1225
  • 36 Bin YS. Is sleep quality more important than sleep duration for public health?. Sleep 2016; 39 (09) 1629-1630
  • 37 Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G. Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 2010; 11 (06) 505-511
  • 38 Morin CM, Benca R. Chronic insomnia. Lancet 2012; 379 (9821) 1129-1141
  • 39 Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331 (7526) 1169
  • 40 Takahashi N, Matsumoto T, Nakatsuka Y. et al; Nagahama Study Group. Differences between subjective and objective sleep duration according to actual sleep duration and sleep-disordered breathing: the Nagahama Study. J Clin Sleep Med 2022; 18 (03) 851-859